#CSL #CSLBehring #garadacimab #hereditaryangioedema #HAE #HAEpatients #EMA #CHMP #factorXIIainhibitor #HAEattacks #CHMPdecision #HAEattacks #HAEattackprevention #Phase3clinicaltrial #VANGUARDclinicaltrial #openlabelextensionstudy
pharmatimes.com/news/csl-rec...
pharmatimes.com/news/csl-rec...
CSL receives positive opinion for garadacimab in hereditary angioedema - PharmaTimes
New treatment could revolutionise care for HAE patients
pharmatimes.com
December 16, 2024 at 3:29 PM